Table 3.
Association between metabolic syndrome components and breast cancer by chi-squared test.
| All subjects | Premenopausal | Postmenopausal | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Case | Control | P | Case | Control | P | Case | Control | P | |
| Waist circumference | 0.003 | 0.010 | 0.104 | ||||||
| ≥80 cm | 283 (47.6%) | 207 (38.9%) | 161 (42.0%) | 111 (32.7%) | 122 (58.4%) | 96 (50.3%) | |||
| <80 cm | 312 (52.4%) | 325 (61.1%) | 222 (58.0%) | 228 (67.3%) | 87 (41.6%) | 95 (49.7%) | |||
| n/a | 0 | 0 | 0 | ||||||
| Fasting serum glucose | 0.186 | 0.133 | 0.734 | ||||||
| ≥5.6 mmol/L | 164 (27.6%) | 126 (24.1%) | 84 (21.9%) | 59 (17.5%) | 80 (38.3%) | 67 (36.6%) | |||
| <5.6 mmol/L | 431 (72.4%) | 397 (75.9%) | 299 (78.1%) | 279 (82.5%) | 129 (61.7%) | 116 (63.4%) | |||
| n/a | 9 | 1 | 8 | ||||||
| Triglycerides | 0.142 | 0.435 | 0.247 | ||||||
| ≥1.7 mmol/L | 101 (17.3%) | 108 (20.7%) | 46 (12.1%) | 47 (14.1%) | 55 (27.1%) | 61 (32.4%) | |||
| <1.7 mmol/L | 484 (82.7%) | 413 (79.3%) | 333 (87.9%) | 286 (85.9%) | 148 (72.9%) | 127 (67.6%) | |||
| n/a | 21 | 10 | 9 | ||||||
| High-density lipoprotein | 0.702 | 0.643 | 0.877 | ||||||
| <1.29 mmol/L | 63 (10.6%) | 51 (9.9%) | 44 (11.5%) | 34 (10.4%) | 18 (8.7%) | 17 (9.1%) | |||
| ≥1.29 mmol/L | 530 (89.4%) | 463 (90.1%) | 339 (88.5%) | 293 (89.6%) | 189 (91.3%) | 169 (90.9%) | |||
| n/a | 20 | 12 | 7 | ||||||
| High blood pressure | 0.147 | 0.294 | 0.262 | ||||||
| Yes | 256 (43.6%) | 204 (39.3%) | 256 (43.6%) | 204 (39.3%) | 124 (59.9%) | 101 (54.3%) | |||
| No | 331 (56.4%) | 315 (60.7%) | 331 (56.4%) | 315 (60.7%) | 83 (40.1%) | 85 (45.7%) | |||
| n/a | 21 | 14 | 7 | ||||||